Related references
Note: Only part of the references are listed.Persister cancer cells: Iron addiction and vulnerability to ferroptosis
Raphae Rodriguez et al.
MOLECULAR CELL (2022)
Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1 /PD-1 immunotherapy
Nikolaos Ioannou et al.
BLOOD (2021)
Ferroptosis: molecular mechanisms and health implications
Daolin Tang et al.
CELL RESEARCH (2021)
A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy
Fushun Fan et al.
CANCER RESEARCH (2021)
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis
Xin Hong et al.
CANCER DISCOVERY (2021)
Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy
Sheera R. Rosenbaum et al.
CANCER DISCOVERY (2021)
Modes of Regulated Cell Death in Cancer
Elle Koren et al.
CANCER DISCOVERY (2021)
CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability
Xingzhe Ma et al.
CELL METABOLISM (2021)
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
Ahmet Sezer et al.
LANCET (2021)
TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis
Zhou Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Pyroptosis: a new paradigm of cell death for fighting against cancer
Yixin Tan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
Chao Mao et al.
NATURE (2021)
Pyroptosis at the forefront of anticancer immunity
Reid Loveless et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Ferroptosis in the tumor microenvironment: perspectives for immunotherapy
Huanji Xu et al.
TRENDS IN MOLECULAR MEDICINE (2021)
Mitochondria as multifaceted regulators of cell death
Florian J. Bock et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
The immune landscape and response to immune checkpoint blockade therapy in lymphoma
Justin Kline et al.
BLOOD (2020)
TGF-β1-mediated repression of SLC7A11 drives vulnerability to GPX4 inhibition in hepatocellular carcinoma cells
Do Hyung Kim et al.
CELL DEATH & DISEASE (2020)
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
Matthew D. Galsky et al.
LANCET (2020)
Targeting apoptosis in cancer therapy
Benedito A. Carneiro et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
Catherine S. Grasso et al.
CANCER CELL (2020)
Plasticity of ether lipids promotes ferroptosis susceptibility and evasion
Yilong Zou et al.
NATURE (2020)
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma
Anusha Kalbasi et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
The Metabolic Underpinnings of Ferroptosis
Jiashuo Zheng et al.
CELL METABOLISM (2020)
Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173/STING-dependent DNA sensor pathway
Enyong Dai et al.
NATURE COMMUNICATIONS (2020)
Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer
Corrin A. Wohlhieter et al.
CELL REPORTS (2020)
Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
Iuliia Efimova et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
The release and activity of HMGB1 in ferroptosis
Qirong Wen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Targeting Ferroptosis to Iron Out Cancer
Behrouz Hassannia et al.
CANCER CELL (2019)
Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study
Radhakrishnan Ramchandren et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
Tony S. K. Mok et al.
LANCET (2019)
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin Wang et al.
NATURE (2019)
Caspases in Cell Death, Inflammation, and Disease
Nina Van Opdenbosch et al.
IMMUNITY (2019)
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087
Robert Chen et al.
BLOOD (2019)
Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11
Xueting Lang et al.
CANCER DISCOVERY (2019)
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Shuang Qin et al.
MOLECULAR CANCER (2019)
The Diversification of Cell Death and Immunity: Memento Mori
Arnaud J. Legrand et al.
MOLECULAR CELL (2019)
Mechanisms Controlling PD-L1 Expression in Cancer
Jong-Ho Cha et al.
MOLECULAR CELL (2019)
FSP1 is a glutathione-independent ferroptosis suppressor
Sebastian Doll et al.
NATURE (2019)
Pyroptosis versus necroptosis: similarities, differences, and crosstalk
Daniel Frank et al.
CELL DEATH AND DIFFERENTIATION (2019)
Role of Mitochondria in Ferroptosis
Minghui Gao et al.
MOLECULAR CELL (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Emerging Strategies of Cancer Therapy Based on Ferroptosis
Zheyu Shen et al.
ADVANCED MATERIALS (2018)
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
Jennifer Tsoi et al.
CANCER CELL (2018)
Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis
Ling-Chu Chang et al.
CANCER LETTERS (2018)
Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma
Behrouz Hassannia et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme
Todd A. Triplett et al.
NATURE BIOTECHNOLOGY (2018)
FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation
Michael M. Gaschler et al.
NATURE CHEMICAL BIOLOGY (2018)
A primer on caspase mechanisms
Monica L. Gonzalez Ramirez et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
Haemin-induced cell death in human monocytic cells is consistent with ferroptosis
Shion Imoto et al.
TRANSFUSION AND APHERESIS SCIENCE (2018)
p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells
Amy Tarangelo et al.
CELL REPORTS (2018)
BAP1 links metabolic regulation of ferroptosis to tumour suppression
Yilei Zhang et al.
NATURE CELL BIOLOGY (2018)
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Christopher S. Garris et al.
IMMUNITY (2018)
Atezolizumab: A PD-L1-Blocking Antibody for Bladder Cancer
Brant A. Inman et al.
CLINICAL CANCER RESEARCH (2017)
Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis
Valerian E. Kagan et al.
NATURE CHEMICAL BIOLOGY (2017)
Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth
Shiro L. Cramer et al.
NATURE MEDICINE (2017)
Necroptotic cell death in anti-cancer therapy
Olga Krysko et al.
IMMUNOLOGICAL REVIEWS (2017)
TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy
Yemsratch T. Akalu et al.
IMMUNOLOGICAL REVIEWS (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al.
LANCET (2017)
NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis
Samantha W. Alvarez et al.
NATURE (2017)
Salinomycin kills cancer stem cells by sequestering iron in lysosomes
Trang Thi Mai et al.
NATURE CHEMISTRY (2017)
The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
Yangchun Xie et al.
CELL REPORTS (2017)
How do we fit ferroptosis in the family of regulated cell death?
Howard O. Fearnhead et al.
CELL DEATH AND DIFFERENTIATION (2017)
PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals
Sally E. Wenzel et al.
CELL (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Programmed cell death and the immune system
Shigekazu Nagata et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Local Activation of p53 in the Tumor Microenvironment Overcomes Immune Suppression and Enhances Antitumor Immunity
Gang Guo et al.
CANCER RESEARCH (2017)
Inhibition of neuronal ferroptosis protects hemorrhagic brain
Qian Li et al.
JCI INSIGHT (2017)
Immunogenic cell death in cancer and infectious disease
Lorenzo Galluzzi et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Loss of cysteinyl-tRNA synthetase ( CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation
M. Hayano et al.
CELL DEATH AND DIFFERENTIATION (2016)
Lack of p53 Augments Antitumor Functions in Cytolytic T Cells
Anirban Banerjee et al.
CANCER RESEARCH (2016)
The Dynamics of Apoptotic Cell Clearance
Michael R. Elliott et al.
DEVELOPMENTAL CELL (2016)
An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model
Matthew Jennis et al.
GENES & DEVELOPMENT (2016)
Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis
Kenichi Shimada et al.
NATURE CHEMICAL BIOLOGY (2016)
Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses
Yang Ou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Ferrootosis: Death by Lipid Peroxidation
Wan Seok Yang et al.
TRENDS IN CELL BIOLOGY (2016)
Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells
S. Ma et al.
CELL DEATH & DISEASE (2016)
The interplay between cell signalling and the mevalonate pathway in cancer
Peter J. Mullen et al.
NATURE REVIEWS CANCER (2016)
Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death
Scott J. Dixon et al.
ACS CHEMICAL BIOLOGY (2015)
TAM Receptor Signaling in Immune Homeostasis
Carla V. Rothlin et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility
Marie-Helene Larraufie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Glutaminolysis and Transferrin Regulate Ferroptosis
Minghui Gao et al.
MOLECULAR CELL (2015)
Ferroptosis as a p53-mediated activity during tumour suppression
Le Jiang et al.
NATURE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Broad targeting of resistance to apoptosis in cancer
Ramzi M. Mohammad et al.
SEMINARS IN CANCER BIOLOGY (2015)
Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: Focusing on mitochondria
Huiqin Zhong et al.
REDOX BIOLOGY (2015)
Perforin and granzymes: function, dysfunction and human pathology
Ilia Voskoboinik et al.
NATURE REVIEWS IMMUNOLOGY (2015)
TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis
Jonathan H. M. van der Meer et al.
BLOOD (2014)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Lysosomal Iron, Iron Chelation, and Cell Death
Alexei Terman et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Glutathione peroxidases
Regina Brigelius-Flohe et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Cellular responses toL-serine inSaccharomyces cerevisiae: roles of general amino acid control, compartmentalization, and aspartate synthesis
Johnny C.-Y. Lee et al.
FEMS YEAST RESEARCH (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
Christophe Louandre et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
Tongyuan Li et al.
CELL (2012)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
The Two Faces of Interferon-γ in Cancer
M. Raza Zaidi et al.
CLINICAL CANCER RESEARCH (2011)
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
I. Martins et al.
ONCOGENE (2011)
The structural basis for membrane binding and pore formation by lymphocyte perforin
Ruby H. P. Law et al.
NATURE (2010)
Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
Theocharis Panaretakis et al.
EMBO JOURNAL (2009)
Apoptosis: controlled demolition at the cellular level
Rebecca C. Taylor et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
Death and anti-death: Tumour resistance to apoptosis
FH Igney et al.
NATURE REVIEWS CANCER (2002)
Share Paper
